Get startedLog in
    Picture of Valiant Laboratories logo

    VALIANTLAB — Valiant Laboratories Balance Sheet

    0.000.00%
    in flag iconLast trade - 00:00
    Basic MaterialsSpeculativeSmall CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual balance sheet for Valiant Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:———
    Source:ARSPROSPECTUSARS
    Standards:
    IAS
    IAS
    IAS
    Status:FinalFinalFinal
    Cash and Equivalents
    Short Term Investments
    Cash and Short Term Investments2013611,438
    Net Total Accounts Receivable
    Net Total Receivables1,124905498
    Total Inventory
    Total Other Current Assets
    Total Current Assets1,4971,5062,255
    Net Property, Plant And Equipment237488927
    Long Term Investments
    Other Long Term Assets
    Total Assets1,7442,1303,427
    Accounts Payable
    Notes Payable / Short Term Debt
    Current Portion of Long Term Debt / Capital Leases
    Total Other Current Liabilities
    Total Current Liabilities420507291
    Long Term Debt
    Capital Lease Obligations
    Total Long Term Debt
    Total Debt
    Deferred Income Tax
    Total Other Liabilities
    Total Liabilities1,0291,1251,058
    Common Stock
    Retained Earnings (Accumulated Deficit)
    Total Equity7151,0052,369
    Total Liabilities & Shareholders' Equity1,7442,1303,427
    Total Common Shares Outstanding